Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Deep Geometric Framework to Predict Antibody-Antigen Binding Affinity

View through CrossRef
In drug development, the efficacy of an antibody depends on how the antibody interacts with the target antigen. The strength of these interactions gives an indication of how successful an antibody is in neutralizing an antigen. Therefore, the strength, measured by “binding affinity”, is a critical aspect of antibody engineering. In theory, the higher the binding affinity, the higher the chances are that the antibody is successful against the target antigen. Currently, techniques such as molecular docking and molecular dynamics are utilized in quantifying the binding affinity. However, owing to the computational complexity of the aforementioned techniques, running simulations for large antibodies/antigens remains a daunting task. Despite the commendable improvements in deep learning-based binding affinity prediction, such approaches are highly dependent on the quality of the antibody-antigen structures and they tend to overlook the importance of capturing the evolutionary details of proteins upon mutation. Further, most of the existing datasets for the task only include antibody-antigen pairs related to one antigen variant and, thus, are not suitable for developing comprehensive data-driven approaches. To circumvent the said complexities, we first curate the largest and most generalized datasets for antibody-antigen binding affinity prediction, consisting of both protein sequences and structures. Subsequently, we propose a deep geometric neural network comprising a structure-based model and a sequence-based model that considers both atomistic and evolutionary details when predicting the binding affinity. The proposed framework exhibited a 10% improvement in mean absolute error compared to the state-of-the-art models while showing a strong correlation between the predictions and target values. We release the datasets and code publicly ( https://drug-discovery-entc.github.io/p2pxml/ ) to support the development of antibody-antigen binding affinity prediction frameworks for the benefit of science and society.
Title: Deep Geometric Framework to Predict Antibody-Antigen Binding Affinity
Description:
In drug development, the efficacy of an antibody depends on how the antibody interacts with the target antigen.
The strength of these interactions gives an indication of how successful an antibody is in neutralizing an antigen.
Therefore, the strength, measured by “binding affinity”, is a critical aspect of antibody engineering.
In theory, the higher the binding affinity, the higher the chances are that the antibody is successful against the target antigen.
Currently, techniques such as molecular docking and molecular dynamics are utilized in quantifying the binding affinity.
However, owing to the computational complexity of the aforementioned techniques, running simulations for large antibodies/antigens remains a daunting task.
Despite the commendable improvements in deep learning-based binding affinity prediction, such approaches are highly dependent on the quality of the antibody-antigen structures and they tend to overlook the importance of capturing the evolutionary details of proteins upon mutation.
Further, most of the existing datasets for the task only include antibody-antigen pairs related to one antigen variant and, thus, are not suitable for developing comprehensive data-driven approaches.
To circumvent the said complexities, we first curate the largest and most generalized datasets for antibody-antigen binding affinity prediction, consisting of both protein sequences and structures.
Subsequently, we propose a deep geometric neural network comprising a structure-based model and a sequence-based model that considers both atomistic and evolutionary details when predicting the binding affinity.
The proposed framework exhibited a 10% improvement in mean absolute error compared to the state-of-the-art models while showing a strong correlation between the predictions and target values.
We release the datasets and code publicly ( https://drug-discovery-entc.
github.
io/p2pxml/ ) to support the development of antibody-antigen binding affinity prediction frameworks for the benefit of science and society.

Related Results

Mesoscale Modeling of a Nucleosome-Binding Antibody (PL2-6): Mono- vs. Bivalent Chromatin Complexes
Mesoscale Modeling of a Nucleosome-Binding Antibody (PL2-6): Mono- vs. Bivalent Chromatin Complexes
ABSTRACTVisualizing chromatin adjacent to the nuclear envelope (denoted “epichromatin”) by in vitro immunostaining with a bivalent nucleosome-binding antibody (termed monoclonal an...
Immune-induced antibody-DNA hybrid condensates
Immune-induced antibody-DNA hybrid condensates
We report here the combined use of Watson-Crick and antibody-antigen interactions to induce phase separation of DNA-antibody hybrid condensates. To achieve this, we have used an an...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
Unidirectional potentiation of binding between two anti‐FBP MAbs: Evaluation of involved mechanisms
Unidirectional potentiation of binding between two anti‐FBP MAbs: Evaluation of involved mechanisms
AbstractThe monoclonal antibody MOv19 directed to a folate binding protein shows temperature‐dependent potentiation of binding of the noncompeting monoclonal antibody MOv18 to the ...
Abstract 1345: NAV-201, an orally bioavailable small molecule NK cell activator enhancing antibody-mediated cancer therapies
Abstract 1345: NAV-201, an orally bioavailable small molecule NK cell activator enhancing antibody-mediated cancer therapies
Abstract Tumors employ a number of mechanisms to suppress a patient’s immune anti-tumor responses. Recently, we uncovered an immunosuppression mechanism that tumors ...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Prediction of protein–carbohydrate complex binding affinity using structural features
Prediction of protein–carbohydrate complex binding affinity using structural features
Abstract Protein–carbohydrate interactions play a major role in several cellular and biological processes. Elucidating the factors influencing the binding affinity o...
Long-Range Electrostatic Interactions Significantly Modulate the Affinity of Dynein for Microtubules
Long-Range Electrostatic Interactions Significantly Modulate the Affinity of Dynein for Microtubules
AbstractThe dynein family of microtubule minus-end directed motor proteins drives diverse functions in eukaryotic cells, including cell division, intracellular transport, and flage...

Back to Top